Compare Equinix Inc (EQIX) vs NeoGenomics Inc. Common Stock (NEO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Equinix Inc vs NeoGenomics Inc. Common Stock — how do they compare? Equinix Inc trades at $973.5 (market cap $98.27B), while NeoGenomics Inc. Common Stock trades at $17.2 (market cap $2.17B). The key difference: Equinix Inc is far larger — about 45.3× NeoGenomics Inc. Common Stock's market cap, and Equinix Inc pays a 2.07% dividend while NeoGenomics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Equinix Inc for 110 Days and NeoGenomics Inc. Common Stock for 0 Days on average.
| EQIX | NEO | |
|---|---|---|
Market Cap | $98.27B | $2.17B |
Volume | 450,557 | 1,615,943 |
Sector | Real Estate | Health |
52-Week High | $1.12K | $19.91 |
52-Week Low | $726.09 | $7.19 |
Typical Hold Time | 110 Days | 0 Days |
Enterprise Value | $119.40B | $2.47B |
Dividend Yield | 2.07% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Equinix (EQIX) trades at $976.98, down 4.16% on the day, reflecting market volatility despite a bullish technical signal from moving averages. The company reported a net income margin of 15.63% for 2025, with revenue growth to $9.22B, though recent quarters show mixed earnings performance with two misses and one beat. Analyst consensus remains strongly bullish with a $1,250 price target, supported by accelerating AI-driven demand for data center capacity.
The outlook is positive due to robust AI infrastructure investments and a 75% buy rating from analysts, but risks include high valuation multiples (P/E 64.09) and significant capital expenditures, with net cash flow negative $1.26B in 2025. Shareholders face exposure to debt levels rising to 47.13% of assets, potentially pressuring equity returns if growth slows.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Equinix Inc
Equinix is a retail provider of data centers, enabling hundreds of enterprise tenants to house their servers and networking equipment in a collocated environment. Tenants can then connect with each other, through cloud service providers and telecom networks. Equinix operates 240 data centers in 66 markets worldwide and owns just less than half of them. The firm has roughly 10,000 customers, including 2,000 networks, that are dispersed over five verticals: Cloud and IT Services, Content Providers, Network and Mobile Services, Financial Services, and Enterprise. About 70% of Equinix's revenue comes from renting space to tenants and related services, and more than 15% comes from connecting customers with each other. Equinix operates as a real estate investment trust.
Read more on EQIX →About NeoGenomics Inc. Common Stock
NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.
Read more on NEO →
